Macrophages as a Source and Target of GDF-15

Lina Susana Silva-Bermudez1,2, Harald Klüter1,2, Julia G Kzhyshkowska1,2

  • 1Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Insights

Growth differentiation factor 15 (GDF-15), a cytokine involved in immune tolerance, interacts with macrophages. Understanding these interactions is key for developing new GDF-15 therapies for various diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Growth differentiation factor 15 (GDF-15) is a cytokine in the TGF-β superfamily.
  • GDF-15 is linked to immune tolerance and elevated in stress conditions, impacting disease severity and prognosis in cancer and metabolic/cardiovascular disorders.
  • Its precise molecular mechanisms and cell-specific effects require further elucidation.

Purpose of the Study:

  • To review the physiological and pathological interactions between GDF-15 and macrophages.
  • To discuss the therapeutic potential and challenges of GDF-15 in clinical translation.

Main Methods:

  • Literature review summarizing existing research on GDF-15 and macrophages.
  • Analysis of GDF-15's role in macrophage function, including cytokine production and phenotype switching.
  • Discussion of current and future therapeutic strategies involving GDF-15.

Main Results:

  • GDF-15 expression is stimulated by inflammatory mediators but often exerts anti-inflammatory and pro-fibrotic effects.
  • Macrophages produce GDF-15 under stress, potentially driving fibrogenesis and angiogenesis.
  • Macrophages can adopt a tolerogenic phenotype in response to GDF-15.

Conclusions:

  • GDF-15 plays a complex, context-dependent role in macrophage biology.
  • Further research into GDF-15-macrophage interactions is crucial for advancing GDF-15-based therapeutics.
  • Therapeutic strategies targeting GDF-15, such as analogs or antibodies, show promise but face challenges in clinical translation.